The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, the perfusionist reported that on the 80% of the oxygenator, the cardioplegia port at the arterial outlet of the oxygenator was loose and leaked during prime.They were able to tightened the connector to stop the leak.No known impact or consequence.The product was not changed out.The procedure was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on november 11, 2019.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added exp date).G4 (date received by manufacturer).G7 (indication that this is a follow-up report).H2 (follow-up due to additional information).H4 (device manufacture date).H6 (identification of evaluation codes 3331, 4114, 3221, 4315).Method code #1: 3331 - analysis of production records.Method code #2: 4114 - device not returned.Results code: 3221 - no findings available.Conclusions code: 4315 - cause not established.The affected sample was not returned for evaluation; therefore a thorough investigation could not be performed.A procedural review was completed on the cardioplegia cap installation.A root cause could not be determined as the unit was not returned.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|